
Psychiatr News June 1, 2007
Volume 42, Number 11, page 16
© 2007 American Psychiatric Association
Surprising Number of People Show Signs of Psychosis
Joan Arehart-Treichel
Researchers have long known that substantial proportions of nonclinical
populations have sub-threshold manifestations of depression and phobia. It is
striking to find that the same is true for psychotic experiences.
A number of people may experience psychotic symptoms even if they do not
have a full-blown psychotic disorder, various studies have suggested. For
example, the first National Comorbidity Survey, published in 1996, found that
28 percent of Americans had experienced psychotic symptoms at some point in
their lives. European studies placed the percentage between 6 percent and 18
percent.
However, none of these studies evaluated how many people experience such
symptoms over the long term. So Wulf Roessler, M.D., a professor of clinical
and social psychiatry at the University of Zurich in Switzerland, and his
colleagues decided to do so.
Results from their 20-year investigation appeared in the May
Schizophrenia Research.
Roessler and his group started with 4,600 19- or 20-year-olds
representative of their age group in the Zurich area. Each was mailed and
asked to fill out the Symptom Checklist 90-R (SCL90-R). The SCL90-R is a
comprehensive self-report questionnaire containing 90 questions, covering a
broad range of psychiatric symptoms. From the individuals who responded, the
researchers selected 591 to participate in their 20-year longitudinal study.
Two-thirds of them had scored high in psychiatric symptoms on the SCL90-R, and
the remaining one-third had scored within the normal range. The reason why
they conducted their inquiry in this fashion, Roessler explained to
Psychiatric News, was "because it is a time- and money-saving
way to conduct longitudinal studies and because one wants to increase the
chances of assessing rare symptoms."
When the subjects were aged 21, 23, 28, 30, 35, and 41, they were asked not
only to fill out the SCL90-R, but to undergo a semistructured interview. This
way the scientists could not just plot their experiences with various
psychotic symptoms, but also diagnose them, according to DSM
criteria, for schizophrenia. Out of the initial 591 subjects, 372 completed
the entire study.
Roessler and his team found that a large proportion58
percentreported having experienced psychotic symptoms at one time or
another. For example, at age 21, 38 percent reported that someone else could
control their thoughts, and 19 percent reported that other people were aware
of their private thoughts. At age 30, 30 percent reported that they felt
lonely even when with other people. At age 41, about 33 percent said they were
being watched by other people.
As time went by, the subjects experiencing psychotic symptoms could
generally be placed in two groupsthose with the nuclear symptoms of
schizophrenia such as auditory hallucinations and thought-broadcasting, and
those with schizotypal symptoms such as odd beliefs, suspiciousness, and a
reduced capacity for close relationships. Nonetheless, 6 out of 10 subjects
who had experienced a consistently high level of schizotypal symptoms also
experienced a continuously high level of schizophrenia nuclear ones, and those
who remained highly symptomatic in either domain experienced a lot of
difficulties in their lives on factors such as partnerships, careers, or
contact with the justice system.
Results Extrapolated
The researchers then extrapolated their findings to the general Swiss
population; that is, they gave more weight to results from subjects who had
initially scored normally on the SCL90-R than to results from subjects who had
initially scored at or above the 85th percentile. Using this procedure, they
found that 6 percent of the general population experienced schizophrenia
nuclear symptoms, and 3 percent experienced schizotypal symptoms at some point
in their lives.
"This study is the most recent in a growing number of reports that
document a much higher prevalence of subthreshold psychotic experiences in the
general population than was previously thought to be the case," Ronald
Kessler, Ph.D., told Psychiatric News. In addition to being a
professor of health care policy at Harvard Medical School, Kessler headed the
National Comorbidity Survey Replication (Psychiatric News, July 15,
2005).
"Importantly," he added, "this study also documented
considerable consistency in these experiences over a two-decade follow-up
period.... We have long known that more common emotional disorders, such as
depression and phobia, are at the upper ends of continuous distributions, with
substantial proportions of the population having subthreshold manifestations.
It is striking to find the same is true for psychotic experiences."
Surprises Appear Among Results
Yet more provocative results emerged from this investigation, Roessler
noted.
For example, while a considerable number of subjects reported psychotic
symptoms throughout the 20-year period, fewer tended to do so as time went on.
Roessler admitted that he wasn't sure of why this occurred, "But what we
do know from the epidemiology of schizophrenia and psychotic disorders is that
we would expect the highest rates of psychotic symptoms to occur in the 20s,
with a constant decline over the two decades of our observation
period."
Also, individuals who reported continuously high levels of the nuclear
symptoms of schizophrenia often had used marijuana in adolescence. Indeed, use
of marijuana at age 20 or 21 was the most prominent predictor for a
continuously high level of schizophrenia nuclear symptoms over the next 20
years. Furthermore, the odds ratios were higher in frequent users, indicating
a dose-response relationship.
In contrast, individuals who reported a continuously high level of
schizotypal symptoms often had experienced troubled childhoods, suggesting
that childhood adversity might be a risk factor for them.
The report, Kessler asserted, "raises important questions about
the... implications of extending research on early preventive intervention
with incipient cases of psychosis to include the substantial number of people
with stable subthreshold symptoms."
Roessler agreed. "Our study gives new impetus to the discussion about
early detection and treatment of schizophrenia. It has been considered
unethical to treat persons below the diagnostic threshold. This should be
re-discussed considering the significant impact of these subthreshold
symptoms."
No easy answers on when treatment should be offered, however, could be
gleaned from this study. For as Roessler pointed out, "We did not find
one person acquiring full-blown schizophrenia. The conclusion is that the
'psychotic states' we identified in our subjects stand for themselves. They
are not just pre-forms of schizophrenia. They are part of the spectrum
disorder from schizotypal personality disorders to full-blown
schizophrenia."
The study was funded by the Swiss National Science Foundation.
An abstract of "Psychotic Experiences in the General
Population: A Twenty-Year Prospective Community Study" can be accessed
at
<www.sciencedirect.com>
by clicking on "S" under "Browse by title," then
"Schizophrenia Research."
Get information about faster international access.
a>
Privacy Policy
Copyright © 2007
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|